RxDoctor Payments Data

John Dillon, MD

Nephrology · Rochester, MNNPI 1932186996

Payments from drug & device makers

What this record shows

That places this record below the midpoint for nephrology clinicians in MN, where the typical reported total is $121.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$175,585in research payments, 2019–2025

Across 11 payments — averaging $15,962 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Fresenius USA Marketing, Inc.$176K

How this compares

$0 in reported general payments places this provider in the 20th percentile of 208 nephrology providers in Minnesota.

See all nephrology providers in Minnesota

Medicare billing

Part B allowed, 2024
$169,169
Medicare patients
159
Services billed
750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol12$6,542
Sevelamer Carbonate19$6,029
ProsolParenteral Amino Acid 20% No.144$5,925
Calcium Acetate21$1,716
Torsemide26$712
Guanfacine Hcl16$516
Metoprolol Succinate15$47

Paid to pharmacies, not to this prescriber.

Other nephrology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →